FindTrial
Sign In

A medical records based study of novel coronavirus pneumonia (COVID-19) and influenza virus co-infection

Co-infection of novel coronavirus pneumonia (COVID-19) and influenza virus: a single-center, two-phase, observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029905
Enrollment
Unknown
Registered
2020-02-16
Start date
2020-02-10
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Influenza patients diagnosed in our center from December 1 to February 28 in the past 5 years (positive throat swab antigens of influenza A, B and H7 subtypes); 2. From December 1, 2019 to February 13, 2020, patients with positive detection of SARS-COV-2 (throat swab) in our center; 3. novel coronavirus (COVID-19) (throat swab) positive patients admitted to our hospital after February 13, 2020 4. Influenza virus antigen/nucleic acid positive patients admitted to our hospital after February 13, 2020

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to sign informed consent; 2. Clinical data is seriously missing or unable to ensure the authenticity of data.

Design outcomes

Primary

MeasureTime frame
Incidence of co-infection;—

Secondary

MeasureTime frame
Age distribution of co-infection;—

Countries

China

Contacts

Public ContactZhao Yan

Zhongnan Hospital of Wuhan University

doctoryanzhao@whu.edu.cn+86 13995577963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026